As African countries accelerate the deployment of COVID-19 (coronavirus) vaccines, the issue of vaccine hesitancy looms. Globally, there has been a rise in general vaccine hesitancy but especially towards COVID-19 vaccines. In Africa, hesitancy must be viewed in the context of significant vaccine shortage; hesitancy does not explain fully the low vaccination rates in Africa. The slow vaccine rollout on the continent is due to supply constraints, structural issues, and logistical barriers.
Deadline: 06-May-2019 at 11:59:59 PM (Eastern Time – Washington D.C.)
In recognition of the serious health challenges and the global dimension of the epidemic threats, the African Union Heads of States and Governments established the Africa Centers for Disease Control and Prevention (CDC) as a specialized agency of the African Union Commission and formally launched its operations on January 31, 2017.
The Africa CDC operates through three levels: (i) a secretariat based at the African Union headquarters (HQ) in Addis Ababa, Ethiopia; (ii) five Regional Collaborating Centers (RCCs) located in Egypt, Gabon, Kenya, Nigeria, and Zambia; and (iii) the National Public Health Institutes (NPHIs) and Centers of Excellence. To assure a coherent network between the RCCs, the NPHIs and Centers of Excellence, Africa CDC launched the Regional Integrated Surveillance and Laboratory Network (RISLNET) as an integrated platform for strengthening national and regional surveillance and laboratory systems; and harnessing existing public health assets for disease prevention.